| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Stephen G. Pauker | Q97318958 |
| P2093 | author name string | J Chard | |
| D A Braunholtz | |||
| R J Lilford | |||
| P2860 | cites work | 'Evidence-based', 'cost-effective' and 'preference-driven' medicine: decision analysis based medical decision making is the pre-requisite | Q33582000 |
| Using decision analysis to calculate the optimum treatment for microinvasive cervical cancer | Q35875935 | ||
| The statistical basis of public policy: a paradigm shift is overdue | Q36600218 | ||
| A cost-utility analysis of laser-assisted angioplasty for peripheral arterial occlusions | Q36805965 | ||
| Prenatal diagnosis: a directive approach to genetic counseling using decision analysis | Q36998522 | ||
| Clinical versus actuarial judgment | Q38612327 | ||
| Comparison of "accelerated" tissue plasminogen activator with streptokinase for treatment of suspected myocardial infarction | Q40936608 | ||
| A consumer's guide to subgroup analyses | Q41111858 | ||
| Trade-off between gestational age and miscarriage risk of prenatal testing: does it vary according to genetic risk? | Q41175483 | ||
| An evidence based approach to individualising treatment | Q41849533 | ||
| The research-practice gap and the role of decision analysis in closing it. | Q48782665 | ||
| Patient-specific decisions about hormone replacement therapy in postmenopausal women. | Q52267210 | ||
| Equipoise and the ethics of randomization. | Q52328438 | ||
| A Bayesian approach to the interpretation of subgroup results in clinical trials. | Q52729449 | ||
| Functional status versus utilities in survivors of myocardial infarction | Q68047158 | ||
| RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 | Q69755626 | ||
| Science in a health service | Q73321164 | ||
| P433 | issue | 7155 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | decision analysis | Q5249226 |
| P304 | page(s) | 405-409 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Decision analysis and the implementation of research findings | |
| P478 | volume | 317 |
| Q40602394 | A model for the future conduct of pharmacovigilance |
| Q58007878 | A model for undertaking effectiveness and cost-effectiveness analyses of primary preventive strategies in cardiovascular disease |
| Q41109879 | A randomized controlled trial of physical activity with individual goal-setting and volunteer mentors to overcome sedentary lifestyle in older adults at risk of cognitive decline: the INDIGO trial protocol |
| Q33629242 | Alcoholic Chlorhexidine or Alcoholic Iodine Skin Antisepsis (ACAISA): protocol for cluster randomised controlled trial of surgical skin preparation for the prevention of superficial wound complications in prosthetic hip and knee replacement surgery |
| Q38049921 | Applying evidence to patient care: from population health to individual patient values |
| Q35018784 | Barriers to research utilisation: the clinical setting and nurses themselves |
| Q60045694 | Benefit of Echocardiography in Patients With Bacteremia at Low Risk of Endocarditis |
| Q35865661 | Benefits and resource implications of family meetings for hospitalized palliative care patients: research protocol |
| Q47628067 | Changes to the statin prescribing policy in Belgium: potential impact in clinical and economic terms |
| Q34092042 | Classifying clinical decision making: a unifying approach |
| Q36956131 | Comparison of listing strategies for allosensitized heart transplant candidates requiring transplant at high urgency: a decision model analysis. |
| Q33916738 | Controversy in primary care: Should asymptomatic haemochromatosis be treated? |
| Q37263911 | Cost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia |
| Q34133994 | Decision analysis and its application in clinical medicine |
| Q50133467 | Decision analysis in evidence-based decision making |
| Q33913336 | Decision analysis: dealing with uncertainty in diagnostic testing |
| Q42657870 | Determining patient characteristics for decision analysis support systems using anonymized electronic patient records |
| Q38404151 | Direct ultrasound localisation for pleural aspiration: translating evidence into action. |
| Q42056457 | Dyspepsia management in the millennium: to test and treat or not? |
| Q28364493 | Effects of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis |
| Q28175859 | Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged > or =70 |
| Q39333440 | Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model |
| Q36660220 | Evaluating child welfare policies with decision-analytic simulation models |
| Q34998773 | Evaluating the effects of increasing physical activity to optimize rehabilitation outcomes in hospitalized older adults (MOVE Trial): study protocol for a randomized controlled trial |
| Q34103118 | Evidence-based medicine as Bayesian decision-making |
| Q91608941 | Extending Delivery Coverage to Include Prenatal Care for Low-Income, Immigrant Women Is a Cost-Effective Strategy |
| Q51901677 | Improving forensic tribunal decisions: the role of the clinician. |
| Q44003637 | Individualizing treatment decisions. The likelihood of being helped or harmed |
| Q37331228 | Information and involvement |
| Q40661527 | Internal medicine -- back to the future of health care delivery |
| Q37206594 | Management of common gastrointestinal disorders: quality criteria based on patients' views and practice guidelines |
| Q35094994 | Meta-analysis and decision analysis bridge research and practice |
| Q42342607 | Money and mission? Addressing the barriers to evidence-based medicine |
| Q35206637 | On what basis should the effectiveness of decision aids be judged? |
| Q34999676 | Operative versus nonoperative management of acute Achilles tendon rupture: expected-value decision analysis |
| Q36729904 | Overview of pharmacoeconomic modelling methods |
| Q90426999 | Personalized risk stratification through attribute matching for clinical decision making in clinical conditions with aspecific symptoms: The example of syncope |
| Q40317253 | Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia |
| Q24812150 | Pretest probability assessment derived from attribute matching |
| Q34347565 | Responding to uncertainty in nursing practice |
| Q43605070 | Should cell-free DNA testing be used to target antenatal rhesus immune globulin administration? |
| Q33738311 | Systematic review of near patient test evaluations in primary care |
| Q34608270 | The clinical decision analysis using decision tree |
| Q33760977 | The effect of mindfulness training prior to total joint arthroplasty on post-operative pain and physical function: study protocol for a randomised controlled trial. |
| Q37333837 | The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis |
| Q37331843 | The role of doctor's opinion in shared decision making: what does shared decision making really mean when considering invasive medical procedures? |
| Q35015818 | The therapeutic challenges in the older Parkinson's disease patient |
| Q36611279 | Toward an evidence-based toxicology |
| Q34021780 | Treating individuals according to evidence: why do primary care practitioners do what they do? |
Search more.